Infant Mental Health-Home Visiting Randomized Controlled Trial (IMH-HV RCT)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03175796|
Recruitment Status : Recruiting
First Posted : June 5, 2017
Last Update Posted : October 17, 2017
The primary objective is to rigorously evaluate the effectiveness of the Infant Mental Health Home Visiting (IMH-HV) model on maternal and child outcomes according to legislative standards via a randomized controlled trial. The research team will recruit caregivers and their children (0-24 months) or pregnant women (n=72) from locations across Washtenaw County to participate in the IMH-HV RCT. Half of the women will be randomly assigned to a treatment as usual (TAU) control group (with access to all available community resources), and half of the women will be randomly assigned to the treatment group (i.e., IMH-HV). Women assigned to the control group will not receive IMH-HV treatment through the study team, but will not be prohibited from seeking or accessing IMH-HV treatment or any other services through community resources. Women assigned to the treatment group will receive IMH-HV treatment for 12 months through the study team with rigorous monitoring of fidelity to the IMH-HV model. All study participants will undergo assessments across the 12-month period of the treatment trial (i.e., baseline (randomization will occur after baseline), mid-points (3, 6 and 9 months) and follow-up (12 months) after randomization).
The purpose of this study is to evaluate efficacy of the Infant Mental Health Home-Visiting (IMH-HV) model on parental and child outcomes according to legislative standards and consistent with the State of Michigan's benchmarks. If this study confirms the efficacy of the IMH-HV model, this will support the sustainability of IMH-HV in the state of Michigan as evidence from a randomized controlled trial is necessary in order to access certain state and federal dollars. Access to evidence-based and sustainable parenting support can ultimately improve outcomes for this vulnerable population. Specifically this study aims to:
- Conduct a randomized controlled trial to evaluate the efficacy of IMH-HV treatment utilizing rigorous outcomes monitoring and evaluation methodology to establish that the families served achieve the intended positive benefit. Eligible caregivers and children or pregnant women will be assigned to the control group or the treatment group and both groups will receive research assessments at regular intervals measuring key impacts of the IMH-HV model.
Determine IMH-HV efficacy via analysis of treatment impact on key caregiver, child, and family indicators. The hypothesis is that there will be positive impacts of IMH-HV, with caregiver, child, and family-level improvements from baseline to post assessment on key indicators, including:
- Improved child outcomes as reflected in strengthened child physical and behavioral health, development and school readiness, and reduced risk for child maltreatment.
- Improved parental outcomes including improved parent mental health, decreased child abuse potential, and enhanced positive parenting.
- Improved family environment including decrease in crime and family violence, enhance linkage to referrals and improve family economics and self-sufficiency.
- Identify factors associated with family improvement, including dosage and fidelity of treatment. It is the hypothesis that a dose-response association between the number of home visiting sessions and treatment impact, and a positive association between fidelity of treatment delivered and positive child and family outcomes.
|Condition or disease||Intervention/treatment||Phase|
|Infant Mental Health||Behavioral: Infant Mental Health-Home Visiting||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||144 participants|
|Intervention Model:||Parallel Assignment|
|Intervention Model Description:||
IMH-HV is a relationship-focused mental health intervention that aims to improve caregiver and child outcomes, including: improved caregiver mental health; enhanced positive parenting; decreased risk for physical/emotional neglect and/or abuse; and reduced risk for negative child outcomes including impaired development, cognitive delay and behavioral problems. In addition, IMH-HV services aim to reduce the probability of intergenerational transmission of the effects of unresolved loss and trauma in parents.
The IMH-HV Model uses a range of strategies for intervention, such as:
|Masking:||None (Open Label)|
|Official Title:||Infant Mental Health-Home Visiting Randomized Controlled Trial|
|Actual Study Start Date :||October 12, 2017|
|Estimated Primary Completion Date :||April 30, 2019|
|Estimated Study Completion Date :||April 30, 2019|
Experimental: IMH-HV Treatment Group
Infant Mental Health-Home Visiting. Weekly home visits for up to one year by a trained IMH-HV treatment provider. Treatment delivery consistent with the IMH-HV manual.
Behavioral: Infant Mental Health-Home Visiting
Behavioral intervention aimed to increase parental competencies and promote mental health and sensitive caregiving.
No Intervention: Treatment as Usual Control Group
No intervention provided as part of participation in this study; families are free to access community resources including any available treatment(s) in the community.
- PTSD Checklist (PCL-5) [ Time Frame: 1 Year ]Change in caregiver PTSD symptoms via measurement on PCL-5 with a range of 0 (no symptoms) to 80 (high level symptom endorsement).
- Generalized Anxiety Disorder (GAD-7) [ Time Frame: 1 Year ]Change in caregiver anxiety via measurement on GAD-7 with a range of 0 (no symptoms) to 21 (high level of anxiety symptoms endorsed).
- Patient Health Questionnaire (PHQ-9) [ Time Frame: 1 Year ]Change in caregiver self-reported depression via measurement on PHQ-9 with a range of 0 (no depression symptoms) to 27 (high level of depression symptoms endorsed).
- Brief Child Abuse Potential Inventory (BCAP) [ Time Frame: 1 Year ]Change in caregiver self-reported emotional distress, rigidity, social isolation (risks associated with child maltreatment) via measurement on BCAP with a range of 0-24.
- Working Model of the Child Interview (WMCI) [ Time Frame: 1 year ]Categorization of caregiver perception of child and relationship with child that moves from distorted or disengaged to balanced via measurement on the WMCI.
- Infant Toddler Social-Emotional Assessment (ITSEA) [ Time Frame: 1 Year ]Change in caregiver reported social-emotional behavior problems of child via measurement on ITSEA using t-scores derived from ITSEA-provided standard norms
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03175796
|Contact: Rachel Waddell, MSW||(734) email@example.com|
|Contact: Emily Alfafara, BA||(734) firstname.lastname@example.org|
|United States, Michigan|
|University of Michigan||Recruiting|
|Ann Arbor, Michigan, United States, 48109|
|Contact: Emily Alfafara 734-998-8145 email@example.com|
|Principal Investigator:||Katherine Rosenblum, PhD||University of Michigan|